Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Medicina (Kaunas) ; 60(4)2024 Apr 04.
Artículo en Inglés | MEDLINE | ID: mdl-38674243

RESUMEN

Background and Objectives: Coronavirus disease 2019 (COVID-19) caused several cardiovascular complications, including acute myocardial infarction (AMI), in infected patients. This study aims to understand the overall trends of AMI among COVID-19 patients during the first two years of the pandemic and the disparities and outcomes between the first and second years. Materials and Methods: The retrospective analysis was conducted via the 2020 and 2021 National Inpatient Sample (NIS) database for hospitalizations between April 2020 and December 2021 being analyzed for adults with a primary diagnosis of COVID-19 who experienced events of AMI. A comparison of month-to-month events of AMI and mortality of AMI patients with concomitant COVID-19 was made alongside their respective patient characteristics. Results: Out of 2,541,992 COVID-19 hospitalized patients, 3.55% experienced AMI. The highest rate of AMI was in December 2021 (4.35%). No statistical differences in trends of AMI mortality were noted over the 21 months. AMI cases in 2021 had higher odds of undergoing PCI (aOR 1.627, p < 0.01). They experienced higher risks of acute kidney injury (aOR 1.078, p < 0.01), acute ischemic stroke (aOR 1.215, p < 0.01), cardiac arrest (aOR 1.106, p < 0.01), need for mechanical ventilation (aOR 1.133, p < 0.01), and all-cause mortality (aOR 1.032, 95% CI 1.001-1.064, p = 0.043). Conclusions: The incidence of AMI among COVID-19 patients fluctuated over the 21 months of this study, with a peak in December 2021. COVID-19 patients reporting AMI in 2021 experienced higher overall odds of multiple complications, which could relate to the exhaustive burden of the pandemic in 2021 on healthcare, the changing impact of the virus variants, and the hesitancy of infected patients to seek care.


Asunto(s)
COVID-19 , Infarto del Miocardio , Humanos , COVID-19/complicaciones , COVID-19/epidemiología , Masculino , Femenino , Infarto del Miocardio/epidemiología , Estudios Retrospectivos , Persona de Mediana Edad , Anciano , SARS-CoV-2 , Pandemias , Adulto , Hospitalización/estadística & datos numéricos , Anciano de 80 o más Años
2.
IDCases ; 32: e01787, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37214186

RESUMEN

Background: Salmonella species are very rarely associated with infective endocarditis, accounting for less than 0.01-2.9 % of total bacterial endocarditis cases. Since 1976, there have less than 90 reported cases of non-Typhoidal Salmonella bacteremia and endocarditis. Case presentation: We present the case of a 57-year-old homeless man with a past medical history significant only for polysubstance abuse. He presented to the emergency department with a 3-day history of severe, non-bloody diarrhea, nausea, chills, and oliguria. Due to the patient's history of substance use, screening laboratory tests were conducted and were positive for rapid plasma reagin, treponemal antibodies, and hepatitis C. For the profuse diarrhea and severe volume loss, C. difficile, stool white blood cells and stool ova and parasites were ordered but were ultimately negative. Both sets of blood cultures were found to be positive for Salmonella Typhimurium bacteremia. Further workup with transthoracic and transesophageal echocardiogram displayed small mobile masses attached to the aortic surface of the right and non-coronary cusps, confirming endocarditis on the aortic valve. Treatment included penicillin-G once a week for 3 weeks for latent syphilis and ceftriaxone and levofloxacin for bacteremia and endocarditis. Conclusions: Patients with Salmonella typically present early with gastrointestinal symptoms, but clinicians should consider cardiovascular imaging if blood cultures are found to be positive in order to potentially identify and promptly treat highly fatal Salmonella endocarditis.

3.
J Cardiovasc Med (Hagerstown) ; 24(9): 642-650, 2023 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-37409665

RESUMEN

AIM: Peri-cardiac catheterization (CC) stroke is associated with increased morbidity and mortality. Little is known about any potential difference in stroke risk between transradial (TR) and transfemoral (TF) approaches. We explored this question through a systematic review and meta-analysis. METHODS: MEDLINE, EMBASE, and PubMed were searched from 1980 to June 2022. Randomized trials and observational studies comparing radial versus femoral access CC or intervention that reported stroke events were included. A random-effects model was used for analysis. RESULTS: The total population in our 41 pooled studies comprised 1 112 136 patients - average age 65 years, women averaging 27% in TR and 31% in TF approaches. Primary analysis of 18 randomized-controlled trials (RCTs) that included a total of 45 844 patients showed that there was no statistical significance in stroke outcomes between the TR approach and the TF approach [odds ratio (OR) 0.71, 95% confidence interval (CI) 0.48-1.06, P -value = 0.013, I2 = 47.7%]. Furthermore, meta-regression analysis of RCTs including procedural duration between those two access sites showed no significance in stroke outcomes (OR 1.08, 95% CI 0.86-1.34, P -value = 0.921, I2 = 0.0%). CONCLUSIONS: There was no significant difference in stroke outcomes between the TR approach and the TF approach.


Asunto(s)
Intervención Coronaria Percutánea , Accidente Cerebrovascular , Femenino , Humanos , Anciano , Factores de Riesgo , Arteria Radial , Arteria Femoral/diagnóstico por imagen , Corazón , Accidente Cerebrovascular/epidemiología , Accidente Cerebrovascular/etiología , Accidente Cerebrovascular/prevención & control , Intervención Coronaria Percutánea/efectos adversos , Resultado del Tratamiento
4.
Int J Angiol ; 28(4): 270-271, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31787828

RESUMEN

Paravalvular aortic regurgitation affects some patients after surgically implanted prosthesis. The number of patients affected is likely to increase with increased utilization of nonsurgical valve replacement techniques. These patients are at increased risk of persistent clinical symptoms often requiring repair. Clinical and procedural outcomes are of importance when performing these procedures and managing these patients. We describe a case where two different leaks around an aortic prosthesis improved with closure of one defect.

5.
Eur J Echocardiogr ; 9(6): 819-21, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18579490

RESUMEN

The safety of dobutamine stress echocardiography (DSE) has been demonstrated in multiple studies with a major complication rate of <1%. Specifically, ventricular tachycardia during DSE has a reported incidence of 0.3%, and has been bound to be of no prognostic significance in patients without obstructive coronary artery disease. We report a unique case of fatal pheochromocytoma crisis precipitated by DSE in a patient with heretofore unknown adrenal disease. We are once again reminded that no diagnostic modality is absolutely without risk; however, minimal they might be.


Asunto(s)
Neoplasias de las Glándulas Suprarrenales/complicaciones , Dobutamina/efectos adversos , Ecocardiografía de Estrés/efectos adversos , Feocromocitoma/complicaciones , Insuficiencia Respiratoria/etiología , Choque/etiología , Simpatomiméticos/efectos adversos , Neoplasias de las Glándulas Suprarrenales/diagnóstico por imagen , Ecocardiografía de Estrés/métodos , Resultado Fatal , Femenino , Humanos , Persona de Mediana Edad , Feocromocitoma/diagnóstico por imagen , Insuficiencia Respiratoria/inducido químicamente , Choque/inducido químicamente
6.
Int J Angiol ; 27(3): 174-176, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30154638

RESUMEN

Some cardiac valve masses may have embolic potential with worrisome consequences. We describe the dilemmas of and solutions for a highly mobile papillary fibroelastoma on the aortic valve in a nonsurgical patient undergoing transcatheter aortic valve replacement. It was performed safely. The potential strategies to minimize the risk of embolization are discussed.

7.
Tex Heart Inst J ; 34(2): 214-7, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17622372

RESUMEN

Friedreich's ataxia is the most common hereditary neurodegenerative disorder, and more than half of all patients show echocardiographic evidence of cardiomyopathy. Although angina has been reported in these patients, the role of coronary artery disease has previously been dismissed and is therefore underestimated. Premature obstructive coronary disease has rarely been angiographically demonstrated in patients with Friedreich's ataxia. We present an unusual case of a 35-year-old woman with Friedreich's ataxia who presented with intermittent chest pressure associated with dyspnea and diaphoresis. Cardiac catheterization revealed a chronically occluded left circumflex coronary artery and a high-grade stenosis of the left anterior descending coronary artery. A Cypher stent, placed within the left anterior descending artery, left no residual stenosis. This case illustrates the importance of fully investigating anginal symptoms in patients with Friedreich's ataxia, because coronary artery disease is likely underdiagnosed in this population. Early diagnosis may permit aggressive management and may delay the progression to end-stage cardiomyopathy.


Asunto(s)
Angina de Pecho/etiología , Estenosis Coronaria/etiología , Ataxia de Friedreich/complicaciones , Adulto , Angina de Pecho/diagnóstico por imagen , Angina de Pecho/fisiopatología , Cateterismo Cardíaco/instrumentación , Circulación Colateral , Angiografía Coronaria , Circulación Coronaria , Estenosis Coronaria/complicaciones , Estenosis Coronaria/diagnóstico , Estenosis Coronaria/fisiopatología , Estenosis Coronaria/terapia , Femenino , Ataxia de Friedreich/diagnóstico por imagen , Ataxia de Friedreich/fisiopatología , Humanos , Stents , Volumen Sistólico , Resultado del Tratamiento , Función Ventricular Izquierda
8.
J Invasive Cardiol ; 21(6): e103-5, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19494414

RESUMEN

Neurofibromatosis (NF) is a genetic disorder inherited in an autosomal dominant pattern. Subtypes I and II are the most well recognized, and among these, Type I has associated vasculopathy. Less than 3% of patients have vascular involvement, with the renal artery as the most commonly involved vessel. Dissection and rupture of aneurysms in larger arteries such as the subclavian and the aorta have been previously reported. This is the first reported case of a spontaneous coronary artery dissection in a patient with NF-I. Imperative in the percutaneous treatment of coronary artery dissections is early recognition and proactive decision making. Recognition of a possible association between NF and coronary dissections will further facilitate successful and prompt management of this otherwise rare entity.


Asunto(s)
Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/etiología , Neurofibromatosis 1/complicaciones , Angioplastia Coronaria con Balón/instrumentación , Angioplastia Coronaria con Balón/métodos , Angiografía Coronaria , Stents Liberadores de Fármacos , Femenino , Humanos , Persona de Mediana Edad , Rotura Espontánea/diagnóstico , Rotura Espontánea/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA